Subdiabetogenic streptozocin treatment impairs preimplantation development of mouse embryos

J Veselá1, P Rehák, V Baran

  • 1Institute of Animal Physiology, Slovak Academy of Sciences, Koŝice.

Physiological Research
|January 1, 1993
PubMed

Insights

Subdiabetic conditions in female mice negatively impact early embryo development. Insulin treatment offers partial protection, but prolonged subdiabetic states increase embryo degeneration.

Area of Science:

  • Reproductive biology
  • Endocrinology
  • Developmental biology

Background:

  • Insulin plays a crucial role in metabolic regulation.
  • Subdiabetic states can affect reproductive outcomes.
  • Preimplantation embryo development is sensitive to maternal metabolic conditions.

Purpose of the Study:

  • To investigate the impact of a subdiabetic state on preimplantation embryo development in mice.
  • To assess the potential protective role of insulin treatment in mitigating these effects.

Main Methods:

  • Female mice were induced into a subdiabetic state using streptozocin at varying times before fertilization.
  • Embryo development was assessed morphologically at day 3 of pregnancy.
  • Insulin treatment was administered to a subset of subdiabetic mice.

Main Results:

  • Subdiabetic mice showed altered preimplantation embryo stage distribution.
  • Continuous insulin treatment improved embryo development in short-term subdiabetic models.
  • Long-term subdiabetic exposure (14-17 days) increased embryo degeneration rates.

Conclusions:

  • A subdiabetic state in female mice impairs preimplantation embryo development.
  • Insulin therapy can partially prevent these developmental impairments.
  • Prolonged subdiabetic conditions exacerbate negative effects on embryo viability.

Related Concept Videos